Which closed-end funds own Biocon Biologics Global PLC?
2 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $1.1M. Security type: debt security. Country: United Kingdom. CUSIP 090978AA5 · ISIN US090978AA56.
Holdings are historical filings (report dates Jun 30, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| EMD Western Asset Emerging Markets Debt Fund | Taxable Bonds | 0.24% | $2M | 2,000,000 par | $852M | 12.4% discount | Jun 30, 2026 |
| BRW Saba Capital Income & Opportunities Fund | U.S. Equity | -0.27% | $-946K | -944,000 par | $351M | 17.8% discount | Jul 31, 2026 |
2 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: Biocon Biologics Global.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Biocon Biologics Global | debt security | 1 |
| Biocon Biologics Global | debt security | 1 |
Issuer-level search for “BIOCON BIOLOGICS GLOBAL PLC” → · Compare two funds’ portfolios →